145 related articles for article (PubMed ID: 28474969)
21. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
J Neuroimmunol; 2013 Jan; 254(1-2):170-3. PubMed ID: 22967351
[TBL] [Abstract][Full Text] [Related]
22. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
Yoshimura S; Isobe N; Matsushita T; Masaki K; Sato S; Kawano Y; Ochi H; Kira J
PLoS One; 2014; 9(4):e95367. PubMed ID: 24736746
[TBL] [Abstract][Full Text] [Related]
23. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.
Kollaee A; Ghaffarpor M; Ghlichnia HA; Ghaffari SH; Zamani M
Int J Immunogenet; 2012 Oct; 39(5):414-22. PubMed ID: 22404765
[TBL] [Abstract][Full Text] [Related]
24. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
Kallaur AP; Oliveira SR; Simão AN; de Almeida ER; Morimoto HK; Lopes J; Pelegrino LM; de Pereira WL; Alfieri DF; Andrade RM; Borelli SD; Watanabe MA; Kaimen-Maciel DR; Reiche EM
J Mol Neurosci; 2014 Jun; 53(2):211-21. PubMed ID: 24696164
[TBL] [Abstract][Full Text] [Related]
26. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
27. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
[TBL] [Abstract][Full Text] [Related]
28. Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.
Furukawa H; Oka S; Kawasaki A; Shimada K; Sugii S; Matsushita T; Hashimoto A; Komiya A; Fukui N; Kobayashi K; Osada A; Ihata A; Kondo Y; Nagai T; Setoguchi K; Okamoto A; Okamoto A; Chiba N; Suematsu E; Kono H; Katayama M; Hirohata S; Sumida T; Migita K; Hasegawa M; Fujimoto M; Sato S; Nagaoka S; Takehara K; Tohma S; Tsuchiya N
PLoS One; 2016; 11(4):e0154255. PubMed ID: 27116456
[TBL] [Abstract][Full Text] [Related]
29.
Brownlee WJ; Tur C; Manole A; Eshaghi A; Prados F; Miszkiel KA; Wheeler-Kingshott CAG; Houlden H; Ciccarelli O
Mult Scler; 2023 Mar; 29(3):333-342. PubMed ID: 36398585
[TBL] [Abstract][Full Text] [Related]
30. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.
Zivadinov R; Uxa L; Zacchi T; Nasuelli D; Ukmar M; Furlan C; Pozzi-Mucelli R; Tommasi MA; Locatelli L; Ulivi S; Bratina A; Bosco A; Grop A; Cazzato G; Zorzon M
J Neurol; 2003 Sep; 250(9):1099-106. PubMed ID: 14504973
[TBL] [Abstract][Full Text] [Related]
31. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
[TBL] [Abstract][Full Text] [Related]
32. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
[TBL] [Abstract][Full Text] [Related]
33. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.
Okuda DT; Srinivasan R; Oksenberg JR; Goodin DS; Baranzini SE; Beheshtian A; Waubant E; Zamvil SS; Leppert D; Qualley P; Lincoln R; Gomez R; Caillier S; George M; Wang J; Nelson SJ; Cree BA; Hauser SL; Pelletier D
Brain; 2009 Jan; 132(Pt 1):250-9. PubMed ID: 19022862
[TBL] [Abstract][Full Text] [Related]
34. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring.
Guijarro-Castro C; Sanchez-Zapardiel E; Munoz D; Fernandez O; Leyva L; Castro-Panete MJ; Picon-Munoz C; Talise M; Martinez-Feito A; Paz-Artal E
Rev Neurol; 2016 Sep; 63(5):201-5. PubMed ID: 27569565
[TBL] [Abstract][Full Text] [Related]
35. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
[TBL] [Abstract][Full Text] [Related]
36. HLA-DQA1*04:01 is related to a higher multiple sclerosis lesion load on T2/Flair MRI sequences.
Noro F; Alves-Leon SV; Fontes-Dantas FL; Valle Bahia PR; Andreiuolo RF; Rueda Lopes FC; Pereira VCSR; Abi-Haila LAA; Coutinho RA; Araujo AD; Marchiori E
Arq Neuropsiquiatr; 2021 Dec; 79(12):1109-1115. PubMed ID: 34877984
[TBL] [Abstract][Full Text] [Related]
37. Association between HLA-DRB1*0405, -DQB1*0401 and -DQA1*0303 alleles and lamotrigine-induced cutaneous adverse drug reactions. A pilot case-control study from Japan.
Ito A; Shimada H; Ishikawa K; Takeo N; Hatano Y; Katagiri K; Kohno K; Araki Y; Terao T; Kojima H; Terao C; Eshima N; Fujiwara S
J Affect Disord; 2015 Jul; 179():47-50. PubMed ID: 25845749
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.
Agliardi C; Guerini FR; Saresella M; Caputo D; Leone MA; Zanzottera M; Bolognesi E; Marventano I; Barizzone N; Fasano ME; Al-Daghri N; Clerici M
Brain Behav Immun; 2011 Oct; 25(7):1460-7. PubMed ID: 21664963
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type).
Ono T; Zambenedetti MR; Yamasaki K; Kawano Y; Kamikawaji N; Ito H; Sakurai M; Nishimura Y; Kira J; Kanazawa I; Sasazuki T
Tissue Antigens; 1998 Dec; 52(6):539-42. PubMed ID: 9894852
[TBL] [Abstract][Full Text] [Related]
40. The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Yates RL; Esiri MM; Palace J; Mittal A; DeLuca GC
Neuropathol Appl Neurobiol; 2015 Apr; 41(3):371-84. PubMed ID: 24964187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
